Tiotropium in asthmatic adolescents symptomatic despite inhaled corticosteroids: A randomised dose-ranging study

Respiratory Medicine

Volumn 108, Issue 9, 2014, Pages 1268-1276

  Vogelberg, Christian ^a   Engel, Michael ^b   Moroni Zentgraf, Petra ^b   Leonaviciute Klimantaviciene, Migle ^c   Sigmund, Ralf ^b   Downie, John ^d   Nething, Katja ^b   Vevere, Viktorija ^e   Vandewalker, Mark ^f  

^a UNIVERSITY HOSPITAL CARL GUSTAV CARUS   (Germany)

^b BOEHRINGER INGELHEIM PHARMA GMBH AND CO KG   (Germany)

^c VILNIUS UNIVERSITY   (Lithuania)

^d BOEHRINGER INGELHEIM PHARMACEUTICALS INC   (United States)

^e Private Practice   (Latvia)

^f Clinical Research of the Ozarks   (United States)

Author keywords

Adolescents; Anticholinergic; Asthma; Bronchodilator; Inhaled corticosteroids; Tiotropium

Indexed keywords

ANTIHISTAMINIC AGENT; CORTICOSTEROID; LEUKOTRIENE; PLACEBO; TIOTROPIUM BROMIDE; BRONCHODILATING AGENT; CHOLINERGIC RECEPTOR BLOCKING AGENT; GLUCOCORTICOID; SCOPOLAMINE DERIVATIVE;

ADD ON THERAPY; ADOLESCENT; ADOLESCENT DISEASE; ARTICLE; ASTHMA; BRONCHITIS; CHILD; CONTROLLED STUDY; CROSSOVER PROCEDURE; DIASTOLIC BLOOD PRESSURE; DISEASE DURATION; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; DRUG WITHDRAWAL; ETHNICITY; FEMALE; FORCED EXPIRATORY VOLUME; HEART RATE; HUMAN; INFLUENZA A (H1N1); MAINTENANCE THERAPY; MAJOR CLINICAL STUDY; MALE; MEDICATION COMPLIANCE; MULTICENTER STUDY; MYCOPLASMA PNEUMONIA; PATIENT COMPLIANCE; PEAK EXPIRATORY FLOW; PHARYNGITIS; PHASE 2 CLINICAL TRIAL; PRESYNCOPE; RANDOMIZED CONTROLLED TRIAL; RHINITIS; RHINOPHARYNGITIS; SINUSITIS; SMOKING; SOFT MIST INHALER; CLINICAL TRIAL; DRUG COMBINATION; DRUG EFFECTS; INHALATIONAL DRUG ADMINISTRATION; PATHOPHYSIOLOGY; TREATMENT OUTCOME;

ADMINISTRATION, INHALATION; ADOLESCENT; ASTHMA; BRONCHODILATOR AGENTS; CHILD; CHOLINERGIC ANTAGONISTS; CROSS-OVER STUDIES; DOSE-RESPONSE RELATIONSHIP, DRUG; DOUBLE-BLIND METHOD; DRUG THERAPY, COMBINATION; FEMALE; FORCED EXPIRATORY VOLUME; GLUCOCORTICOIDS; HUMANS; MALE; PEAK EXPIRATORY FLOW RATE; SCOPOLAMINE DERIVATIVES; TREATMENT OUTCOME;

EID: 84913610500     PISSN: 09546111     EISSN: 15323064     Source Type: Journal    
DOI: 10.1016/j.rmed.2014.06.011     Document Type: Article

References (19)

1. Global Initiative for Asthma. Global strategy for asthma management and prevention. Updated 2012. Available from: http://www.ginasthma.org/local/uploads/files/GINA-Report-2012Feb13.pdf [accessed 06.12.13].
2. M. Masoli, D. Fabian, S. Holt, R. Beasley, and Global Initiative for Asthma (GINA) program The global burden of asthma: executive of the GINA Dissemination Committee report Allergy 59 2004 469 478
3. J.K. Schmier, R. Manjunath, M.T. Halpern, M.L. Jones, K. Thompson, and G.B. Diette The impact of inadequately controlled asthma in urban children on quality of life and productivity Ann Allergy Asthma Immunol 98 2007 245 251
4. M. Desai, and J.J. Oppenheimer Medication adherence in the asthmatic child and adolescent Curr Allergy Asthma Rep 11 2011 454 464
5. J. Haughney, D. Price, A. Kaplan, H. Chrystyn, R. Horne, and N. May Achieving asthma control in practice: understanding the reasons for poor control Respir Med 102 2008 1681 1693
6. K.R. Chapman, L.P. Boulet, R.M. Rea, and E. Franssen Suboptimal asthma control: prevalence, detection and consequences in general practice Eur Respir J 31 2008 320 325
7. M.R. Partridge, T. van der Molen, S.E. Myrseth, and W.W. Busse Attitudes and actions of asthma patients on regular maintenance therapy: the INSPIRE study BMC Pulm Med 6 2006 13
8. K.F. Rabe, M. Adachi, C.K. Lai, J.B. Soriano, P.A. Vermeire, and K.B. Weiss Worldwide severity and control of asthma in children and adults: the global asthma insights and reality surveys J Allergy Clin Immunol 114 2004 40 47
9. National Heart, Lung, and Blood Institute Expert panel report 3: guidelines for the diagnosis and management of asthma 2007 Available from: http://www.nhlbi.nih.gov/guidelines/asthma/asthgdln.htm [accessed 15.11.13]
10. G. Rodrigo, C. Rodrigo, and O. Burschtin A meta-analysis of the effects of ipratropium bromide in adults with acute asthma Am J Med 107 1999 363 370
11. D.P. Tashkin, B. Celli, S. Senn, D. Burkhart, S. Kesten, and S. Menjoge A 4-year trial of tiotropium in chronic obstructive pulmonary disease N Engl J Med 359 2008 1543 1554
12. C. Vogelmeier, B. Hederer, T. Glaab, H. Schmidt, M.P.M.H. Rutten-van Mölken, and K.M. Beeh Tiotropium versus salmeterol for the prevention of exacerbations of COPD N Engl J Med 364 2011 1093 1103
13. E.D. Bateman, O. Kornmann, P. Schmidt, A. Pivovarova, M. Engel, and L.M. Fabbri Tiotropium is noninferior to salmeterol in maintaining improved lung function in B16-Arg/Arg patients with asthma J Allergy Clin Immunol 128 2011 315 322
14. H.A.M. Kerstjens, B. Disse, W. Schröder-Babo, T.A. Bantje, M. Gahlemann, and R. Sigmund Tiotropium improves lung function in patients with severe uncontrolled asthma: a randomized controlled trial J Allergy Clin Immunol 128 2011 308 314
15. H.A.M. Kerstjens, M. Engel, R. Dahl, P. Paggiaro, E. Beck, and M. Vandewalker Tiotropium in asthma poorly controlled with standard combination therapy N Engl J Med 367 2012 1198 1207
16. X. Wang, D.W. Dockery, D. Wypij, D.R. Gold, F.E. Speizer, and J.H. Ware Pulmonary function growth velocity in children 6 to 18 years of age Am Rev Respir Dis 148 1993 1502 1508
17. E.F. Juniper, P.M. O'Byrne, G.H. Guyatt, P.J. Ferrie, and D.R. King Development and validation of a questionnaire to measure asthma control Eur Respir J 14 1999 902 907
18. S. Senn, J. Lillienthal, F. Patalano, and D. Till An incomplete blocks cross-over in asthma: a case study in collaboration J. Vollmar, L.A. Hothorn, Biometrics in the pharmaceutical industry 7: cross-over clinical trials 1997 Gustav Fischer Verlag Stuttgart 3 26
19. M.R. Littner, J.S. Ilowite, D.P. Tashkin, M. Friedman, C.W. Serby, and S.S. Menjoge Long-acting bronchodilation with once-daily dosing of tiotropium (Spiriva) in stable chronic obstructive pulmonary disease Am J Respir Crit Care Med 161 2000 1136 1142